Sharps Technology, Inc. (NASDAQ:STSS) Sees Large Increase in Short Interest

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 60,000 shares, a growth of 38.6% from the October 31st total of 43,300 shares. Approximately 3.5% of the shares of the stock are short sold. Based on an average trading volume of 81,700 shares, the days-to-cover ratio is presently 0.7 days.

Sharps Technology Price Performance

Shares of STSS traded down $0.21 on Friday, hitting $3.76. The company’s stock had a trading volume of 14,359 shares, compared to its average volume of 187,408. The company has a market capitalization of $6.76 million, a P/E ratio of -0.47 and a beta of 1.19. Sharps Technology has a fifty-two week low of $2.34 and a fifty-two week high of $18.15.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Sharps Technology stock. Garden State Investment Advisory Services LLC acquired a new position in shares of Sharps Technology, Inc. (NASDAQ:STSS) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned approximately 9.61% of Sharps Technology as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 17.17% of the company’s stock.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.